{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:50:57Z","timestamp":1782226257721,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022e07020054"],"award-info":[{"award-number":["2022e07020054"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["202103a07020012"],"award-info":[{"award-number":["202103a07020012"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03996-4","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:11:03Z","timestamp":1761887463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An integrative analysis of transcriptome, methylome and single-cell RNA sequencing data identifies UBE2H as a marker of oxaliplatin resistance in colorectal cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinman","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"3996_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3996_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"3996_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100759","volume":"8","author":"Z Yu","year":"2021","unstructured":"Yu Z, Deng P, Chen Y, et al. Inhibition of the PLK1-coupled cell cycle machinery overcomes resistance to oxaliplatin in colorectal cancer. Adv Sci. 2021;8:e2100759.","journal-title":"Adv Sci"},{"key":"3996_CR4","first-page":"7855","volume":"29","author":"DL Hertz","year":"2021","unstructured":"Hertz DL, Dockter TJ, Satele DV, Loprinzi CL, Le-Rademacher J. Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912). Support Care Cancer. 2021;29:7855\u201363.","journal-title":"Support Care Cancer"},{"key":"3996_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039049","volume":"103","author":"YF Qian","year":"2024","unstructured":"Qian YF, Chen HP, Ren GF. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: a case report. Medicine (Baltimore). 2024;103:e39049.","journal-title":"Medicine (Baltimore)"},{"key":"3996_CR6","first-page":"33","volume":"13","author":"JS Macdonald","year":"1999","unstructured":"Macdonald JS. Toxicity of 5-fluorouracil. Oncology (Williston Park). 1999;13:33\u20134.","journal-title":"Oncology (Williston Park)"},{"key":"3996_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-015-0348-2","volume":"16","author":"H Kawakami","year":"2015","unstructured":"Kawakami H, Zaanan A, Sinicrope FA. Microsatellite instability testing and its role in the management of colorectal cancer. Curr Treat Options Oncol. 2015;16:30.","journal-title":"Curr Treat Options Oncol"},{"key":"3996_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00132-5","volume":"4","author":"SB Ye","year":"2020","unstructured":"Ye SB, Cheng YK, Zhang L, et al. Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer. NPJ Precis Oncol. 2020;4:26.","journal-title":"NPJ Precis Oncol"},{"key":"3996_CR9","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1038\/s41598-023-33153-8","volume":"13","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Ni K, Liu Z, et al. Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen. Sci Rep. 2023;13:8969.","journal-title":"Sci Rep"},{"key":"3996_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s13402-022-00728-y","volume":"45","author":"G Chen","year":"2022","unstructured":"Chen G, Gong T, Wang Z, et al. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cell Oncol. 2022;45:1155\u201367.","journal-title":"Cell Oncol"},{"key":"3996_CR11","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1002\/jcp.26406","volume":"233","author":"HH Hsu","year":"2018","unstructured":"Hsu HH, Chen MC, Baskaran R, et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018;233:5458\u201367.","journal-title":"J Cell Physiol"},{"key":"3996_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","volume":"26","author":"AW Lambert","year":"2024","unstructured":"Lambert AW, Zhang Y, Weinberg RA. Cell-intrinsic and microenvironmental determinants of metastatic colonization. Nat Cell Biol. 2024;26:687\u201397.","journal-title":"Nat Cell Biol"},{"key":"3996_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:955\u201361.","journal-title":"Nucleic Acids Res"},{"key":"3996_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JJ Smith","year":"2010","unstructured":"Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138:958\u201368.","journal-title":"Gastroenterology"},{"key":"3996_CR15","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1158\/0008-5472.CAN-14-1592","volume":"74","author":"MK Tripathi","year":"2014","unstructured":"Tripathi MK, Deane NG, Zhu J, et al. Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer. Cancer Res. 2014;74:6947\u201357.","journal-title":"Cancer Res"},{"key":"3996_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejca.2017.02.003","volume":"76","author":"M Del Rio","year":"2017","unstructured":"Del Rio M, Mollevi C, Bibeau F, et al. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. Eur J Cancer. 2017;76:68\u201375.","journal-title":"Eur J Cancer"},{"key":"3996_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa L, de Reynies A, Duval A, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10:e1001453.","journal-title":"PLoS Med"},{"key":"3996_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/irad178","author":"X Fei","year":"2023","unstructured":"Fei X, Zhu M, Li X. Characterization of cell type abundance and gene expression timeline from burned skin bulk transcriptomics by deconvolution. J Burn Care Res. 2023. https:\/\/doi.org\/10.1093\/jbcr\/irad178.","journal-title":"J Burn Care Res"},{"key":"3996_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"3996_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327.","journal-title":"Biostatistics"},{"key":"3996_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"H-O Lee","year":"2020","unstructured":"Lee H-O, Hong Y, Etlioglu HE, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52:594\u2013603.","journal-title":"Nat Genet"},{"key":"3996_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108269","volume":"113","author":"M Zhu","year":"2024","unstructured":"Zhu M, Sun X, Fang J, Li X. Deconvolution of cell-type-associated markers predictive of response to neoadjuvant radiotherapy. Comput Biol Chem. 2024;113:108269.","journal-title":"Comput Biol Chem"},{"key":"3996_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nmeth.1439","volume":"7","author":"SS Shen-Orr","year":"2010","unstructured":"Shen-Orr SS, Tibshirani R, Khatri P, et al. Cell type-specific gene expression differences in complex tissues. Nat Methods. 2010;7:287\u20139.","journal-title":"Nat Methods"},{"key":"3996_CR24","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3996_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang LG, Yan GR, He QY. DOSE: an R\/bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 2015;31:608\u20139.","journal-title":"Bioinformatics"},{"key":"3996_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"3996_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3996_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"3996_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"3996_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"3996_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110413","volume":"27","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Fu M, Qi J, et al. Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer. iScience. 2024;27:110413.","journal-title":"iScience"},{"key":"3996_CR32","doi-asserted-by":"crossref","unstructured":"Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression 2016:arXiv:1602.08678. Available from URL: https:\/\/ui.adsabs.harvard.edu\/abs\/2016arXiv160208678P accessed February 01, 2016.","DOI":"10.1214\/16-AOAS920"},{"key":"3996_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2013","unstructured":"Morris TJ, Butcher LM, Feber A, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2013;30:428\u201330.","journal-title":"Bioinformatics"},{"key":"3996_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol. 1972;34:187\u2013202.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"3996_CR35","first-page":"1456","volume":"7","author":"JT Ryan","year":"2013","unstructured":"Ryan JT. The lasso problem and uniqueness. Electronic Journal of Statistics. 2013;7:1456\u201390.","journal-title":"Electronic Journal of Statistics"},{"key":"3996_CR36","volume-title":"Breakthroughs in Statistics: Methodology and Distribution","author":"EL Kaplan","year":"1992","unstructured":"Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. In: Kotz S, Johnson NL, editors. Breakthroughs in Statistics: Methodology and Distribution. NY: Springer, New York; 1992."},{"key":"3996_CR37","doi-asserted-by":"crossref","unstructured":"Borgan \u00d8. Modeling Survival Data: Extending the Cox Model. Terry M. Therneau and Patricia M. Grambsch, Springer-Verlag, New York, 2000. No. of pages: xiii + 350. Price: $69.95. ISBN 0-387-98784-3. Statistics in Medicine. 2001;20: 2053-2054","DOI":"10.1002\/sim.956"},{"key":"3996_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"A Koch","year":"2015","unstructured":"Koch A, De Meyer T, Jeschke J, Van Criekinge W. Mexpress: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16:636.","journal-title":"BMC Genomics"},{"key":"3996_CR39","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","volume":"89","author":"M Frommer","year":"1992","unstructured":"Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89:1827\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3996_CR40","doi-asserted-by":"crossref","unstructured":"Shen C-H. Chapter 9 - Amplification of Nucleic Acids. In: Shen C-H, editor. Diagnostic Molecular Biology: Academic Press, 2019:215-247.","DOI":"10.1016\/B978-0-12-802823-0.00009-2"},{"key":"3996_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris TJ, Butcher LM, Feber A, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30:428\u201330.","journal-title":"Bioinformatics"},{"key":"3996_CR42","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","volume":"39","author":"PS Filippou","year":"2020","unstructured":"Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020;39:2040\u201354.","journal-title":"Oncogene"},{"key":"3996_CR43","first-page":"12644","volume":"8","author":"SL Tang","year":"2015","unstructured":"Tang SL, Gao YL, Chen XB. Wnt\/\u03b2-catenin up-regulates Midkine expression in glioma cells. Int J Clin Exp Med. 2015;8:12644\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"3996_CR44","doi-asserted-by":"publisher","first-page":"37124","DOI":"10.1074\/jbc.M405254200","volume":"279","author":"PR Reynolds","year":"2004","unstructured":"Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem. 2004;279:37124\u201332.","journal-title":"J Biol Chem"},{"key":"3996_CR45","first-page":"2197","volume":"13","author":"Y Adachi","year":"1996","unstructured":"Adachi Y, Matsubara S, Pedraza C, et al. Midkine as a novel target gene for the Wilms\u2019 tumor suppressor gene (WT1). Oncogene. 1996;13:2197\u2013203.","journal-title":"Oncogene"},{"key":"3996_CR46","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41590-024-01909-7","volume":"25","author":"O Fesneau","year":"2024","unstructured":"Fesneau O, Thevin V, Pinet V, et al. An intestinal TH17 cell-derived subset can initiate cancer. Nat Immunol. 2024;25:1637\u201349.","journal-title":"Nat Immunol"},{"key":"3996_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0984-3","volume":"3","author":"A Fatima","year":"2020","unstructured":"Fatima A, Irmak D, Noormohammadi A, et al. The ubiquitin-conjugating enzyme UBE2K determines neurogenic potential through histone H3 in human embryonic stem cells. Commun Biol. 2020;3:262.","journal-title":"Commun Biol"},{"key":"3996_CR48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/jhg.2015.64","volume":"60","author":"K Hirayasu","year":"2015","unstructured":"Hirayasu K, Arase H. Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations. J Hum Genet. 2015;60:703\u20138.","journal-title":"J Hum Genet"},{"key":"3996_CR49","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41419-020-02992-y","volume":"11","author":"M Charan","year":"2020","unstructured":"Charan M, Das S, Mishra S, et al. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Cell Death Dis. 2020;11:774.","journal-title":"Cell Death Dis"},{"key":"3996_CR50","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1136\/gutjnl-2022-329349","volume":"72","author":"X Liu","year":"2023","unstructured":"Liu X, Tang R, Xu J, et al. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma. Gut. 2023;72:2329\u201343.","journal-title":"Gut"},{"key":"3996_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04038-1","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen X, Gao Y, Xie J, et al. Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases. J Transl Med. 2023;21:203.","journal-title":"J Transl Med"},{"key":"3996_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01908","volume":"8","author":"C Xia","year":"2017","unstructured":"Xia C, Braunstein Z, Toomey AC, Zhong J, Rao X. S100 proteins as an important regulator of macrophage inflammation. Front Immunol. 2017;8:1908.","journal-title":"Front Immunol"},{"key":"3996_CR53","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1038\/s41388-021-01932-0","volume":"40","author":"H Sun","year":"2021","unstructured":"Sun H, Zhou R, Zheng Y, et al. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. Oncogene. 2021;40:5342\u201355.","journal-title":"Oncogene"},{"key":"3996_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28107-4","volume":"8","author":"A Castell","year":"2018","unstructured":"Castell A, Yan Q, Fawkner K, et al. A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation. Sci Rep. 2018;8:10064.","journal-title":"Sci Rep"},{"key":"3996_CR55","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1002\/hep.32079","volume":"74","author":"L Ma","year":"2021","unstructured":"Ma L, Xu A, Kang L, et al. LSD1-demethylated LINC01134 confers oxaliplatin resistance through SP1-induced p62 transcription in HCC. Hepatology. 2021;74:3213\u201334.","journal-title":"Hepatology"},{"key":"3996_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00990-0","author":"Z Ahmad","year":"2024","unstructured":"Ahmad Z, Kahloan W, Rosen ED. Transcriptional control of metabolism by interferon regulatory factors. Nat Rev Endocrinol. 2024. https:\/\/doi.org\/10.1038\/s41574-024-00990-0.","journal-title":"Nat Rev Endocrinol"},{"key":"3996_CR57","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1023\/A:1008213732429","volume":"9","author":"E Raymond","year":"1998","unstructured":"Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9:1053\u201371.","journal-title":"Ann Oncol"},{"key":"3996_CR58","first-page":"537","volume":"11","author":"H Nguyen","year":"1995","unstructured":"Nguyen H, Mustafa A, Hiscott J, Lin R. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding\/transcription repression domain. Oncogene. 1995;11:537\u201344.","journal-title":"Oncogene"},{"key":"3996_CR59","first-page":"4531","volume":"13","author":"N Tanaka","year":"1993","unstructured":"Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol. 1993;13:4531\u20138.","journal-title":"Mol Cell Biol"},{"key":"3996_CR60","doi-asserted-by":"publisher","first-page":"25401","DOI":"10.1074\/jbc.M213037200","volume":"278","author":"A Masumi","year":"2003","unstructured":"Masumi A, Yamakawa Y, Fukazawa H, Ozato K, Komuro K. Interferon regulatory factor-2 regulates cell growth through its acetylation. J Biol Chem. 2003;278:25401\u20137.","journal-title":"J Biol Chem"},{"key":"3996_CR61","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","volume":"55","author":"S Lukhele","year":"2022","unstructured":"Lukhele S, Rabbo DA, Guo M, et al. The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity. Immunity. 2022;55:2369-2385.","journal-title":"Immunity"},{"key":"3996_CR62","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon BG, Kuo F, Ji L, et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity. 2022;55:2044-2058.","journal-title":"Immunity"},{"key":"3996_CR63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12967-021-03054-3","volume":"19","author":"Y-J Chen","year":"2021","unstructured":"Chen Y-J, Luo S-N, Dong L, et al. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer. J Transl Med. 2021;19:379.","journal-title":"J Transl Med"},{"key":"3996_CR64","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NC, Lamy L, et al. Irf4 addiction in multiple myeloma. Nature. 2008;454:226\u201331.","journal-title":"Nature"},{"key":"3996_CR65","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.bcp.2006.06.002","volume":"72","author":"M Solis","year":"2006","unstructured":"Solis M, Goubau D, Romieu-Mourez R, Genin P, Civas A, Hiscott J. Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages. Biochem Pharmacol. 2006;72:1469\u201376.","journal-title":"Biochem Pharmacol"},{"key":"3996_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13059-023-03070-0","volume":"25","author":"C Viner","year":"2024","unstructured":"Viner C, Ishak Charles A, Johnson J, et al. Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabet. Genome Biol. 2024;25:11.","journal-title":"Genome Biol"},{"key":"3996_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115199","volume":"44","author":"S Bachoo","year":"2025","unstructured":"Bachoo S, Gudgeon N, Mann R, et al. IL-7 promotes integrated glucose and amino acid sensing during homeostatic CD4+ T cell proliferation. Cell Rep. 2025;44:115199.","journal-title":"Cell Rep"},{"key":"3996_CR68","doi-asserted-by":"publisher","first-page":"15549","DOI":"10.1016\/S0021-9258(18)98652-7","volume":"266","author":"S Qin","year":"1991","unstructured":"Qin S, Nakajima B, Nomura M, Arfin SM. Cloning and characterization of a Saccharomyces cerevisiae gene encoding a new member of the ubiquitin-conjugating protein family. J Biol Chem. 1991;266:15549\u201354.","journal-title":"J Biol Chem"},{"key":"3996_CR69","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1096\/fj.02-0759com","volume":"17","author":"YP Li","year":"2003","unstructured":"Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2\/E220k. FASEB j. 2003;17:1048\u201357.","journal-title":"FASEB j"},{"key":"3996_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093398","author":"KH Lim","year":"2020","unstructured":"Lim KH, Joo JY. Predictive potential of circulating Ube2h mRNA as an E2 ubiquitin-conjugating enzyme for diagnosis or treatment of Alzheimer\u2019s disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093398.","journal-title":"Int J Mol Sci"},{"key":"3996_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biology10050378","volume":"10","author":"M-C Yen","year":"2021","unstructured":"Yen M-C, Wu K-L, Liu Y-W, et al. Ubiquitin conjugating enzyme E2 H (UBE2H) is linked to poor outcomes and metastasis in lung adenocarcinoma. Biol. 2021;10:378.","journal-title":"Biol"},{"key":"3996_CR72","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"3996_CR73","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1200\/JCO.2020.38.15_suppl.4013","volume":"38","author":"JF Seligmann","year":"2020","unstructured":"Seligmann JF, Group FC, Group FC. FOxTROT: neoadjuvant FOLFOX chemotherapy with or without panitumumab (Pan) for patients (pts) with locally advanced colon cancer (CC). J Clin Oncol. 2020;38:4013\u20134013.","journal-title":"J Clin Oncol"},{"key":"3996_CR74","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc1740","volume":"5","author":"R Bjerkvig","year":"2005","unstructured":"Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJA. The origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer. 2005;5:899\u2013904.","journal-title":"Nat Rev Cancer"},{"key":"3996_CR75","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature09781","volume":"469","author":"JE Visvader","year":"2011","unstructured":"Visvader JE. Cells of origin in cancer. Nature. 2011;469:314\u201322.","journal-title":"Nature"},{"key":"3996_CR76","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cmet.2025.01.002","volume":"37","author":"NTB Nguyen","year":"2025","unstructured":"Nguyen NTB, Gevers S, Kok RNU, et al. Lactate controls cancer stemness and plasticity through epigenetic regulation. Cell Metab. 2025;37:903-919.","journal-title":"Cell Metab"},{"key":"3996_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41416-022-02116-7","volume":"128","author":"RM O\u2019Brien","year":"2023","unstructured":"O\u2019Brien RM, Lynam-Lennon N, Olcina MM. Thinking inside the box: intracellular roles for complement system proteins come into focus. Br J Cancer. 2023;128:165\u20137.","journal-title":"Br J Cancer"},{"key":"3996_CR78","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017;127:780\u20139.","journal-title":"J Clin Invest"},{"key":"3996_CR79","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","volume":"14","author":"M Zhan","year":"2023","unstructured":"Zhan M, Ding Y, Huang S, et al. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nat Commun. 2023;14:3123.","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1186\/s12935-025-04098-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000}}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03996-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:02:22Z","timestamp":1767600142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-03996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03996-4","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The corresponding author has been updated in the article PDF.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12935-025-04098-x","URL":"https:\/\/doi.org\/10.1186\/s12935-025-04098-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Human Ethics Committee of the Hefei Cancer Hospital, Chinese Academy of Science and performed under the ethical guidelines of the Helsinki Declaration (SL-KY2022033). All participants provided written informed consent prior to their enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}